Microbiota, co-metabolites, and network pharmacology reveal the alteration of the ginsenoside fraction on inflammatory bowel disease.
Journal Information
Full Title: J Ginseng Res
Abbreviation: J Ginseng Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Integrative & Complementary Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of competing interest The authors declare no conflict of interest."
"Funding This work was supported by the 10.13039/501100012166National Key Research and Development Program of China [2017YFC1702100], the 10.13039/501100001809National Natural Science Foundation of China [81603276, U19A2013 and 82004099], the 10.13039/501100011789Department of Science and Technology of Jilin Province [20190101010JH, 20200201419JC and 202002053JC], and the Science and Technology Projects in Jilin Province Department of Education [JJKH20200903KJ]. Key Laboratory of Active Substances and Biological Mechanisms of Ginseng Efficacy, Ministry of Education. Jilin Provincial Key Laboratory of Bio-Macromolecules of Chinese Medicine."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025